Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5209144 | 0.82 | KLK7 (0.31) | KLK7 | |
| SCHEMBL4178736 | 0.82 | ABHD10 (0.36) | — | |
| SCHEMBL4186152 | 0.81 | KLK7 (0.31) | KLK7 | |
| SCHEMBL7089729 | 0.76 | ABCB1 (0.41) | KLK7 | |
| SCHEMBL7089731 | 0.76 | ABCB1 (0.41) | KLK7 | |
| SCHEMBL5212952 | 0.73 | ADORA2B (0.37) | KLK7 | |
| SCHEMBL5210226 | 0.73 | ALDH1A1 (0.41) | KLK7 | |
| SCHEMBL14492354 | 0.69 | NR1H2 (0.34) | — | |
| SCHEMBL4182803 | 0.67 | ABHD10 (0.36) | — | |
| SCHEMBL4172882 | 0.65 | ABHD10 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090186868-A1 | Taxane Compound Having Azetidine Ring Structure | DAIICHI SANKYO COMPANY LIMITED (JP) | 2009-07-23 | — | — | US | disclosed |
| EP-1942109-A1 | TAXANE COMPOUND WITH AZETIDINE RING STRUCTURE | Daiichi Sankyo Company, Limited (JP) | 2008-07-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090186868-A1 | Taxane Compound Having Azetidine Ring Structure | ABCC1, AZI2, TPD52L2 | KLK7 3535/4885SCN9A 486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.